IRVINE, Calif., Mar. 20, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology
Title: "Circulating Cell-Free DNA Methylation Assay: Towards Early Detection of Multiple Cancer Types"Authors: Dhruvajyoti Roy, David Taggart, Lianghong Zheng, Dan Liu, Gen Li, Mingzhen Li, Kang Zhang, Richard A. Van EttenSession Date: Sunday, March 31Session Time: 1:00 p.m. – 5:00 p.m. EDTPoster Session location: Section 36
Meeting abstracts are available at AACR's website.
About Laboratory for Advanced Medicine
LAM is a commercial-stage medical technology company focused on developing innovative, noninvasive, nontoxic technologies for the early diagnosis and intervention of cancers. The company is dedicated to building and growing world-class technologies from the laboratory to the clinic.
Headquartered in the United States with offices in California, Texas and Indiana, LAM has collaborations with leading scientists, physicians, research institutions and business leaders in the U.S. and China, combining their experiences to provide the most effective and safest diagnostic technologies to patients and their doctors. The company has CLIA-registered and CAP-accredited as well as third-party laboratories and cGMP facilities all working toward bringing first-class technologies to the medical community today.
View original content:http://www.prnewswire.com/news-releases/lam-to-present-data-for-cell-free-dna-methylation-assay-for-non-invasive-diagnosis-of-liver-breast-and-colorectal-cancers-at-aacr-annual-meeting-2019-300815397.html
SOURCE Laboratory for Advanced Medicine (LAM)
Subscribe to our Free Newsletters!